Australia Biobank Market Size & Outlook, 2023-2030
Australia biobank market, 2018-2030 (US$M)
Related Markets
Australia biobank market highlights
- The Australia biobank market generated a revenue of USD 882.7 million in 2023 and is expected to reach USD 1,874.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.4% from 2024 to 2030.
- In terms of segment, biobanking equipment was the largest revenue generating product in 2023.
- LIMS is the most lucrative product segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2023 | USD 882.7 million |
| Market revenue in 2030 | USD 1,874.7 million |
| Growth rate | 11.4% (CAGR from 2023 to 2030) |
| Largest segment | Biobanking equipment |
| Fastest growing segment | LIMS |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Australia accounted for 1.2% of the global biobank market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biobank market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,169.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia biobank market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 77.12% in 2023. Horizon Databook has segmented the Australia biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
The Australian Health Biobank acts as the national agency for collection of biological samples from citizens. The biobank promotes the adoption of research activities and is funded by the Australian Department of Health.
The country also has the presence of several other biobanks, including the Australian Breast Cancer Tissue Bank, Human Studies Unit - Institute for Molecular Bioscience Saint Lucia, South Australian Cancer Research Biobank, and Victorian Cancer Biobank.
Moreover, the country has developed much of the infrastructure necessary for supporting the development of large-scale population-based biobanks. Similarly, the increasing focus on bio specimen collections and associated cohort studies in Australia are expected to generate a high demand for biobanking services in the near future.
Reasons to subscribe to Australia biobank market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia biobank market databook
-
Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biobank market , including forecasts for subscribers. This country databook contains high-level insights into Australia biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia biobank market size, by product, 2018-2030 (US$M)
Australia Biobank Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
